Sai Ravi Pingali

1.8k total citations
63 papers, 529 citations indexed

About

Sai Ravi Pingali is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Sai Ravi Pingali has authored 63 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 20 papers in Hematology. Recurrent topics in Sai Ravi Pingali's work include Lymphoma Diagnosis and Treatment (22 papers), CNS Lymphoma Diagnosis and Treatment (9 papers) and Multiple Myeloma Research and Treatments (8 papers). Sai Ravi Pingali is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), CNS Lymphoma Diagnosis and Treatment (9 papers) and Multiple Myeloma Research and Treatments (8 papers). Sai Ravi Pingali collaborates with scholars based in United States, India and China. Sai Ravi Pingali's co-authors include Swaminathan P. Iyer, Kartik Anand, Joe Ensor, Ethan Burns, Richard E. Champlin, Barry Trachtenberg, Youli Zu, Lawrence Rice, Vivek Subbiah and Xinyu Nan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sai Ravi Pingali

54 papers receiving 522 citations

Peers

Sai Ravi Pingali
Amer Beitinjaneh United States
Denise Pereira United States
Sumie Tabata Japan
Ivan Moiseev Russia
Emma Vernon United States
Andreas K. Klein United States
Christina Dickson United States
Kenji Fukuno Japan
Laura Bellio Italy
Teena Bhatla United States
Amer Beitinjaneh United States
Sai Ravi Pingali
Citations per year, relative to Sai Ravi Pingali Sai Ravi Pingali (= 1×) peers Amer Beitinjaneh

Countries citing papers authored by Sai Ravi Pingali

Since Specialization
Citations

This map shows the geographic impact of Sai Ravi Pingali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sai Ravi Pingali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sai Ravi Pingali more than expected).

Fields of papers citing papers by Sai Ravi Pingali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sai Ravi Pingali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sai Ravi Pingali. The network helps show where Sai Ravi Pingali may publish in the future.

Co-authorship network of co-authors of Sai Ravi Pingali

This figure shows the co-authorship network connecting the top 25 collaborators of Sai Ravi Pingali. A scholar is included among the top collaborators of Sai Ravi Pingali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sai Ravi Pingali. Sai Ravi Pingali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Giese, Noah, et al.. (2024). Management Considerations and Challenges in Older Individuals with Diffuse Large B-cell Lymphoma. Medical Research Archives. 12(5).
3.
Burns, Ethan, Noah Giese, Chih-Hang Anthony Tang, et al.. (2024). Primary Vitreoretinal Lymphoma with or without Intracranial Involvement: A Single Center Experience. Blood. 144(Supplement 1). 1716–1716.
4.
Burns, Ethan, Ibrahim N. Muhsen, Chih‐Chi Andrew Hu, et al.. (2023). Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry. Annals of Hematology. 102(5). 1111–1120. 3 indexed citations
5.
Friend, Brian D., Ibrahim N. Muhsen, Shreeya Patel, et al.. (2022). Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplantation. 57(4). 579–585. 1 indexed citations
6.
Pingali, Sai Ravi, Javier Pinilla‐Ibarz, Michael L. Atchison, et al.. (2022). Loss of AID exacerbates the malignant progression of CLL. Leukemia. 36(10). 2430–2442. 1 indexed citations
7.
Youssef, J.G., George J. Youssef, Sriram Padmanabhan, et al.. (2021). G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?. Annals of Hematology. 100(3). 667–673. 20 indexed citations
8.
Wang, Qiang, Zhijuan Lin, Zhuo Wang, et al.. (2021). RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 139(1). 59–72. 16 indexed citations
9.
Anand, Kartik, Joe Ensor, Sai Ravi Pingali, et al.. (2020). T-cell lymphoma secondary to checkpoint inhibitor therapy. Journal for ImmunoTherapy of Cancer. 8(1). e000104–e000104. 33 indexed citations
10.
Burns, Ethan, Ibrahim N. Muhsen, John Rogers, et al.. (2020). Primary and Secondary Central Nervous System Lymphoma: Outcomes from Houston Methodist Cancer Center. Blood. 136(Supplement 1). 16–17.
11.
Kasparian, Saro, et al.. (2020). Recurrent small bowel obstruction caused by Burkitt lymphoma in an elderly man: a case report and review of the literature. Journal of Medical Case Reports. 14(1). 127–127. 4 indexed citations
12.
Anand, Kartik, Ethan Burns, Joe Ensor, et al.. (2020). Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors. ESMO Open. 5(4). e000866–e000866. 44 indexed citations
13.
Anand, Kartik, Ethan Burns, Joe Ensor, Lawrence Rice, & Sai Ravi Pingali. (2019). Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review. Clinical Lymphoma Myeloma & Leukemia. 20(1). 18–23. 21 indexed citations
14.
Kasparian, Saro, et al.. (2018). Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib. ecancermedicalscience. 12. 836–836. 9 indexed citations
15.
Epperla, Narendranath, Namrata Shah, George Carrum, et al.. (2017). Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 17(7). 408–414. 8 indexed citations
16.
Nan, Xinyu, Joe Ensor, Jasleen K. Randhawa, et al.. (2017). An Integer Weighted Genomic Mutation Score (GMS) Using Next Generation Sequencing Is Predictive of Prognosis in Intermediate Risk AML Patients. Blood. 130. 3940–3940. 1 indexed citations
17.
Hammerstrom, Aimee, Sai Ravi Pingali, Gabriela Rondón, et al.. (2017). Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(2). 353–358. 37 indexed citations
18.
Nieto, Yago, Benigno C. Valdez, Sai Ravi Pingali, et al.. (2017). High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan. The Lancet Haematology. 4(6). e283–e292. 13 indexed citations
19.
Pingali, Sai Ravi & Richard E. Champlin. (2015). Pushing the envelope—nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation. Bone Marrow Transplantation. 50(9). 1157–1167. 21 indexed citations
20.
Pingali, Sai Ravi, Michelle A. Mathiason, Steven D. Lovrich, & Ronald S. Go. (2009). Emergence of Chronic Myelogenous Leukemia From a Background of Myeloproliferative Disorder: JAK2V617F as a Potential Risk Factor for BCR-ABL Translocation. Clinical Lymphoma & Myeloma. 9(5). E25–E29. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amer Beitinjaneh Breakdown of academic impact, for papers by Denise Pereira Breakdown of academic impact, for papers by Sumie Tabata Breakdown of academic impact, for papers by Ivan Moiseev Breakdown of academic impact, for papers by Emma Vernon Breakdown of academic impact, for papers by Andreas K. Klein Breakdown of academic impact, for papers by Christina Dickson Breakdown of academic impact, for papers by Kenji Fukuno Breakdown of academic impact, for papers by Laura Bellio Breakdown of academic impact, for papers by Teena Bhatla
Rankless by CCL
2026